Canada’s regulatory approach to drugs for rare diseases: orphan drugs

Description

Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.

Resources

Name Format Description Link
Canada’s regulatory approach to drugs for rare diseases: orphan drugs HTML https://www.canada.ca/en/health-canada/services/licences-authorizations-registrations-drug-health-products/regulatory-approach-drugs-rare-diseases.html
Canada’s regulatory approach to drugs for rare diseases: orphan drugs HTML https://www.canada.ca/fr/sante-canada/services/licences-autorisation-et-enregistrement-medicaments-et-produits-sante/approche-canada-reglementation-medicaments-maladies-rares.html

Tags

Topics

Categories